Mutans streptococci in xerostomic cancer patients after pilocarpine therapy: A pilot study

The reduced MS counts associated with improved saliva flow rates following pilocarpine therapy in this short-term pilot study are encouraging, but further investigation in a larger group of patients over a longer study period is indicated.